Compare AIXI & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIXI | FLGC |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 7.6M |
| IPO Year | 2023 | 2021 |
| Metric | AIXI | FLGC |
|---|---|---|
| Price | $0.37 | $6.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 243.3K | 35.4K |
| Earning Date | 12-26-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $48,877,458.00 | ★ $57,609,000.00 |
| Revenue This Year | $26.84 | N/A |
| Revenue Next Year | N/A | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.71 |
| 52 Week Low | $0.33 | $5.86 |
| 52 Week High | $6.08 | $47.00 |
| Indicator | AIXI | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 33.26 | 43.99 |
| Support Level | $0.33 | $6.17 |
| Resistance Level | $0.40 | $8.07 |
| Average True Range (ATR) | 0.05 | 0.61 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 23.75 | 48.42 |
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.